Clinical Trials
107 trialsCHIPOR
UNICANCER
PHASE II EVALUATION OF CYTOREDUCTION SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (CRS/HIPEC) IN GASTRIC CANCER
Banner Health
Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study
Mayo Clinic
ProphyloCHIP
Gustave Roussy, Cancer Campus, Grand Paris
HIPEC
Wake Forest University Health Sciences
CHIPPI
Centre Oscar Lambret
Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not
The Affiliated Hospital of Qingdao University
Charlie-2
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Raltitrexed in HIPEC
Fudan University
HIPEC-PMP
University of Southampton
Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer
Ohio State University Comprehensive Cancer Center
ICARuS
Memorial Sloan Kettering Cancer Center
Effects of HIPEC on Postoperative Bowel Motility and Complications
Peking University People's Hospital
G-PEC
Ukrainian Society of Clinical Oncology
HORIZON
Mayo Clinic
A Prospective, Phase II Clinical Study of HIPEC Combined With NIPS and Tislelizumab Conversion Therapy for Gastric Cancer With Peritoneal Metastasis With Positive Cytology Alone or PCI Score ≤10
Hebei Medical University
Treatment of Primary Peritoneal Carcinosis of Digestive Origin Using Cytoreductive Surgery and Hyperthermic Intraoperative Peritoneal Chemotherapy With Mitomycin C and Irinotecan
Hospices Civils de Lyon
Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis
Mayo Clinic
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
City of Hope Medical Center
INTERACT Stomach-II
Erasmus Medical Center
PERISCOPEII
The Netherlands Cancer Institute
The Efficacy and Safety of HIPEC Combined With PD-1 and SOX Chemotherapy for the Translational Treatment of GC or EGJC With PM
The First Affiliated Hospital with Nanjing Medical University
Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer
Loma Linda University
The Safety and Effectiveness of Hyperthermic Intraperitoneal Chemotherapy Combined With Intravenous Chemotherapy for Peritoneal Metastatic Pancreatic Cancer, a Phase II Clinical Trial
Shanghai Zhongshan Hospital
A Clinical Study Evaluating the Efficacy of Systemic Chemotherapy and Immune Checkpoint Inhibitors Combined With Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer Patients With Peritoneal Metastasis
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
TOASTIT
Mayo Clinic
Prophylactic HIPEC for Colorectal Cancers at High Risk of Developing Peritoneal Metastases
National Cancer Centre, Singapore
A Prospective Cohort Study on the Treatment of Locally Advanced Gastric Cancer
Southwest Hospital, China
An Audit of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Tata Memorial Centre
Development and Validation of a Prediction Model for AKI Following Cisplatin-Based HIPEC in Patients With Ovarian Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
CRS/HIPEC
Mercy Medical Center
HIPEC for Peritoneal Carcinomatosis
Albert Einstein College of Medicine
GECOP-MMC
Hospital Universitario de Fuenlabrada
Heated Mitomycin and Cisplatin During Surgery in Treating Patients With Stomach or Gastroesophageal Cancer
M.D. Anderson Cancer Center
Cy-plus
Peking University
Intraperitoneal LSTA1 in CRS-HIPEC
University of California, San Diego
Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for PARP Inhibitors Resistance Patients
Fudan University
CHIMERA
Jagiellonian University
OvIP1
University Hospital, Ghent
HIPEC After Radical Cystectomy for High Risk Bladder Cancer
Weill Medical College of Cornell University
Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility Study
Cantonal Hospital of St. Gallen
HIPEC in Ovarian Carcinoma Clinical Stage IIIC and IV During Interval Laparotomy
Instituto Nacional de Cancerologia de Mexico
Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal Carcinomatosis
Instituto do Cancer do Estado de São Paulo
The Efficacy of Hyperthermic Intraperitoneal Chemotherapy to Ovarian Cancer Patients With Homologous Recombination Repair Defect and Residual: a Prospective Cohort Study
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients
University of Kansas Medical Center
HIPEC Combined Gastrectomy in Patients With Advanced Gastric Cancer Received Neoadjuvant Chemotherapy
Tongji Hospital
A Nomogram to Predict Major Postoperative Complications After Cytoreductive Surgery and HIPEC Based on Pre and Peroperative Criteria: Which Patient Require Intensive Monitoring?
CHU de Reims
Intraperitoneal Chemotherapy Guided by the Detection of DNA in Peritoneal Lavage Fluid in Patients With Gastric Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers
Holy Name Medical Center, Inc.
A Study With Intraperitoneal Cisplatin and Doxorubicin in Recurrent Ovarian Cancer and Peritoneal Carcinomatosis
Ruhr University of Bochum